Insider: Yu Yong VP, Clinical Trial Operations - GENELUX Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 47,640 | 0 | 47,640 |
| Value | $200,088.00 | $0.00 | $200,088.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/12/2025 | DDS | 5,579 | Direct | COM | $2.92 | $16,290.68 | 47,640 |
| 05/29/2024 | AAP | 2,500 | Direct | COM | $0.00 | $0.00 | 2,500 |
| 12/15/2023 | DDS | 26,732 | Direct | COM | $12.94 | $345,914.75 | 5,803 |
| 12/15/2023 | DDS | 5,803 | Direct | COM | $14.18 | $82,265.07 | 0 |
| 12/07/2023 | DDS | 36,800 | Direct | COM | $11.85 | $435,995.36 | 32,535 |
| 11/21/2023 | DDS | 18,665 | Direct | COM | $10.26 | $191,555.16 | 69,335 |
| 11/20/2023 | DDS | 14,594 | Direct | COM | $11.26 | $164,261.31 | 88,000 |
| 11/17/2023 | DDS | 3,541 | Direct | COM | $13.04 | $46,169.68 | 102,594 |
| 10/24/2023 | DDS | 5,200 | Direct | COM | $19.11 | $99,351.20 | 106,135 |
| 10/10/2023 | DDS | 4,800 | Direct | COM | $21.94 | $105,299.52 | 106,535 |
| 10/10/2023 | DDS | 400 | Direct | COM | $22.91 | $9,162.40 | 106,135 |
| 09/26/2023 | DDS | 2,203 | Direct | COM | $24.46 | $53,890.45 | 106,135 |
| 09/26/2023 | DDS | 1,883 | Direct | COM | $22.54 | $42,442.26 | 109,452 |
| 09/26/2023 | DDS | 1,114 | Direct | COM | $23.51 | $26,195.15 | 108,338 |
| 09/20/2023 | DDS | 6,000 | Direct | COM | $27.96 | $167,785.80 | 106,135 |
| 09/15/2023 | DDS | 5,725 | Direct | COM | $21.56 | $123,418.41 | 110,810 |
| 09/15/2023 | DDS | 4,675 | Direct | COM | $22.29 | $104,211.83 | 106,135 |
| 09/13/2023 | DDS | 29,800 | Direct | COM | $21.14 | $629,927.30 | 106,135 |
| 08/30/2023 | DDS | 19,800 | Direct | COM | $24.70 | $489,060.00 | 135,935 |
| 08/18/2023 | DDS | 3,265 | Direct | COM | $23.73 | $77,478.45 | 155,735 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research